Literature DB >> 10631855

Prostatic adenocarcinoma diagnosed by urinary cytology.

B Krishnan1, L D Truong.   

Abstract

Prostatic adenocarcinoma rarely may involve the urinary bladder. Prostatic adenocarcinoma and high-grade transitional cell carcinoma (TCC) may coexist and account for the malignant cells seen in urinary cytology. Differentiating prostatic adenocarcinoma cells from those of TCC is important for therapy but remains difficult. A 10-year retrospective search identified 250 patients with high-grade carcinoma in urinary cytology. Among them, 6 cases of tissue-documented prostate adenocarcinoma were identified. The cytologic features of these cases were compared with those of 15 similarly documented cases of high-grade TCC. By using these criteria, 2 additional cases of prostatic adenocarcinoma were diagnosed prospectively. An oval nucleus with smooth borders; fine, powdery, evenly distributed nuclear chromatin and a large prominent nucleolus when present; and lack of significant pleomorphism are most helpful to differentiate prostatic adenocarcinoma from high-grade TCC. Recognizing these cells may be the first clue for the diagnosis of prostate adenocarcinoma.

Entities:  

Mesh:

Year:  2000        PMID: 10631855     DOI: 10.1309/4t6h-549r-capj-fey0

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Suspicious urinary cytology with negative evaluation for malignancy in the diagnostic investigation of haematuria: how to follow up?

Authors:  G Nabi; D Greene; M O O'Donnell; M O Donnel
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

Review 2.  Approaches to urinary detection of prostate cancer.

Authors:  Jillian N Eskra; Daniel Rabizadeh; Christian P Pavlovich; William J Catalona; Jun Luo
Journal:  Prostate Cancer Prostatic Dis       Date:  2019-01-17       Impact factor: 5.554

3.  Voided urine test to diagnose prostate cancer: Preliminary report.

Authors:  R B Nerli; Shridhar C Ghagane; Saziya R Bidi; Madhukar L Thakur; Leonard Gomella
Journal:  Cytojournal       Date:  2021-10-02       Impact factor: 2.091

Review 4.  The present and future of prostate cancer urine biomarkers.

Authors:  Marina Rigau; Mireia Olivan; Marta Garcia; Tamara Sequeiros; Melania Montes; Eva Colás; Marta Llauradó; Jacques Planas; Inés de Torres; Juan Morote; Colin Cooper; Jaume Reventós; Jeremy Clark; Andreas Doll
Journal:  Int J Mol Sci       Date:  2013-06-17       Impact factor: 5.923

5.  A retrospective study of prostate cancer cases mimicking urothelial cell carcinoma of the bladder.

Authors:  Ranlu Liu; Xiaoqiang Xie; Zhihong Zhang; Yong Xu
Journal:  Eur J Med Res       Date:  2013-10-03       Impact factor: 2.175

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.